Work

Abstract 4356: OBI-902, a novel TROP2 targeted antibody-drug conjugate via GlycOBI® platform, has favorable pharmacokinetics and sustained antitumor activities in challenging solid tumors

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4356

Authors: Ren-Yu Hsu, Chi-Huan Lu, Chi-Sheng Shia, Hsin-Shan Wu, Lu-Tzu Chen, Jhih-Jie Yang, Jyy-Shiuan Tu, Hui-Wen Chang, Shih-Ni Wen, Ming-Tain Lai, Ya-Chi Chen

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409627333

Cites:

Cited by: 1

Related to: 10